FDA Import Refusal SCS-3885306-2/10002/1 — Apotex Inc.
The FDA refused shipment SCS-3885306-2/10002/1 from Apotex Inc. (Canada) on Apr 24, 2026. The refused product falls under Drugs and Biologics — RIVAROXABAN. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 24, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61LDB42 RIVAROXABAN
- Charges
- 75